Stay updated with breaking news from Rax Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Praxis Precision Medicines Inc (NASDAQ: PRAX) has seen a decline in its stock price by -7.27 in relation to its previous close of 1.65. However, the company has experienced a -10.53% decline in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-08-28 that BOSTON, Aug. 2
while the 36-month beta value is 2.70. The public float for PRAX is 114.25M, and currently, short sellers hold a 2.17% ratio of that floaft. The average trading volume of PRAX on October 02, 2023 was 1.01M shares. PRAX) stock’s latest price update Praxis Precision Medicines Inc (NASDAQ: PRAX)
compared to its average ratio and a 36-month beta value of 2.79. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.” The average price point forecasted by analysts for Praxis P
while the 36-month beta value is 2.92.Analysts have differing opinions on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.” The public float for PRAX is 128.04M, and currently, short sellers hold a 2.12%
Additionally, the 36-month beta value for PRAX is 2.94. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.” The average price predicted by analysts